Embecta Corp.
EMBCNasdaqCIK 1872789HealthcareFiscal year ends Sep 30
Reports and events: 63 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0714:28 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001872789-26-000033 |
| 2026-08-0707:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-26-000029 |
| 2026-07-3116:35 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001872789-26-000026 |
| 2026-05-1509:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000546 |
| 2026-05-0513:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001872789-26-000017 |
| 2026-05-0506:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-26-000014 |
| 2026-03-2020:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000947871-26-000310 |
| 2026-02-1317:25 ET | 8-K | 5.07 Shareholder vote results | 0000947871-26-000153 |
| 2026-02-0511:26 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001872789-26-000009 |
| 2026-02-0506:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-26-000005 |
| 2025-12-1816:16 ET | DEF 14A | Proxy statementPeriod 2026-02-11 | 0001140361-25-046025 |
| 2025-11-2516:05 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001872789-25-000036 |
| 2025-11-2507:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-25-000033 |
| 2025-11-1717:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000947871-25-001028 |
| 2025-08-0811:44 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001872789-25-000029 |
| 2025-08-0807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-25-000025 |
| 2025-05-2208:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001872789-25-000016 |
| 2025-05-0911:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001872789-25-000012 |
| 2025-05-0906:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-25-000009 |
| 2025-02-1416:30 ET | 8-K | 5.07 Shareholder vote results | 0000947871-25-000163 |
| 2025-02-0612:25 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001872789-25-000006 |
| 2025-02-0607:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-25-000003 |
| 2024-12-1916:17 ET | DEF 14A | Proxy statementPeriod 2025-02-12 | 0001140361-24-049945 |
| 2024-12-1116:52 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001872789-24-000037 |
| 2024-12-0216:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000947871-24-000973 |
| 2024-11-2606:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-24-000031 |
| 2024-08-1217:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000947871-24-000673 |
| 2024-08-0912:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001872789-24-000028 |
| 2024-08-0907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-24-000026 |
| 2024-05-0913:37 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001872789-24-000019 |
| 2024-05-0907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-24-000016 |
| 2024-04-0516:11 ET | 10-K/A | Annual report, amendedPeriod 2023-09-30 | 0001872789-24-000013 |
| 2024-03-2817:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001872789-24-000010 |
| 2024-02-0916:30 ET | 8-K | 5.07 Shareholder vote results | 0000947871-24-000101 |
| 2024-02-0912:31 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001872789-24-000006 |
| 2024-02-0906:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-24-000003 |
| 2023-12-1916:15 ET | DEF 14A | Proxy statementPeriod 2024-02-07 | 0001140361-23-058411 |
| 2023-11-2916:31 ET | 10-K | Annual reportPeriod 2023-09-30 | 0001872789-23-000031 |
| 2023-11-2106:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001872789-23-000029 |
| 2023-08-0813:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001872789-23-000026 |
| 2023-08-0807:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-23-000024 |
| 2023-08-0316:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000947871-23-000814 |
| 2023-07-0517:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001872789-23-000021 |
| 2023-05-1212:36 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001872789-23-000013 |
| 2023-05-1207:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-23-000011 |
| 2023-02-1413:48 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001872789-23-000006 |
| 2023-02-1407:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001872789-23-000003 |
| 2023-02-1316:12 ET | 8-K | 5.07 Shareholder vote results | 0000947871-23-000158 |
| 2022-12-3016:31 ET | DEF 14A | Proxy statementPeriod 2023-02-09 | 0001140361-22-047672 |
| 2022-12-2215:42 ET | 10-K | Annual reportPeriod 2022-09-30 | 0001872789-22-000024 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.